G. Targher
Epidemiology · 2000–2024
A researcher in the Science corpus: 15 papers; trusts 21 researchers and is trusted by 11 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 249 citations into it; #260 of 2,148 by trust here, #272 by citations
- Endocrinology, Diabetes and Metabolism — 161 citations into it; #65 of 623 by trust here, #88 by citations
- Hepatology — 92 citations into it; #25 of 151 by trust here, #65 by citations
- Molecular Biology — 61 citations into it
- Physiology — 51 citations into it
- Surgery — 45 citations into it
- Pathology and Forensic Medicine — 40 citations into it; #167 of 414 by trust here, #114 by citations
- Immunology — 17 citations into it
Whom G. Targher trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Hotamışlıgil
- Z. Younossi
- P. Tontonoz
- A. Lonardo
- M. Talim
- Herbert Tilg
- Christopher D. Byrne
- N. Chalasani
- Q. Anstee
- L. Adams
Who trusts G. Targher overall
- Christopher D. Byrne
- V. Samuel
- Z. Younossi
- A. Lonardo
- Melania Gaggini
- Herbert Tilg
- Gerald I. Shulman
- K. Cusi
- Q. Anstee
- N. Chalasani
Papers from G. Targher's perspective
Ordered by how strongly the researchers G. Targher trusts endorse each paper. Same corpus, a different order for every researcher.
- Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
- Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity (Annals medicus)
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
- Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity (Hepatology)
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (Nature Reviews Gastroenterology &Hepatology)
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis (Journal of Gastroenterology and Hepatology)
- Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy (Journal of Magnetic Resonance Imaging)
- Association between Non-invasive Fibrosis Markers and Mortality among Adults with Non-alcoholic Fatty Liver Disease in the United States (Hepatology)
- Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression (Cell)
Their papers
- MASLD: a systemic metabolic disorder with cardiovascular and malignant complications (2024) — 738 citations
- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments (2021) — 731 citations
- A new definition for metabolic associated fatty liver disease: an international expert consensus statement. (2020) — 3,051 citations
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications (2020) — 710 citations
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? (2018) — 662 citations
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases (2017) — 1,030 citations
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis (2016) — 637 citations
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. (2016) — 1,217 citations
- NAFLD: a multisystem disease. (2015) — 2,771 citations
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (2013) — 1,661 citations
- Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (2010) — 1,751 citations
- Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. (2009) — 1,093 citations
- High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes (2008) — 672 citations
- HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. (2002) — 634 citations
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. (2000) — 2,548 citations